首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1561027

药用辅料市场规模、份额、成长分析、按产品、按配方、按功能应用、按地区 - 行业预测，2024-2031 年

Pharmaceutical Excipients Market Size, Share, Growth Analysis, By Product, By Formulation, By Functionality, By Functionality Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月19日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球药用辅料市场规模为94.8亿美元，从2023年的101.2亿美元成长到2031年的171.3亿美元，在预测期内（2024-2031年）预计复合年增长率为6.8。

全球药用辅料市场是製药业的关键组成部分，包括与活性药物成分 (API) 一起使用的物质，以帮助药品的配方、稳定性和交付。粘合剂、润滑剂、崩坏和填充剂等赋形剂在确保药品的功效和安全性方面发挥重要作用。由于人口老化、慢性病的增加以及药物输送系统的进步，对先进製剂的需求不断增加，市场正在扩大。此外，赋形剂越来越多地用于新型药物製剂的开发，例如控制释放和标靶治疗。我们的研究还表明，对辅料品质日益严格的监管审查正在影响市场动态，促使製造商关注合规性和创新性。

市场概况
有机化学品
- 油脂化学品
- 脂醇类
- 矿物硬脂酸盐
- 甘油
- 其他油脂化学品
- 碳水化合物
- 醣类
- 砂糖
- 糖醇
- 人工甜味剂
- 纤维素
- 结晶纤维素
- 纤维素醚
- CMC & 交联羧甲基纤维素钠
- 纤维素酯
- 淀粉
- 改质淀粉
- 干淀粉
- 变性淀粉
- 石化产品
- 乙二醇
- 聚维酮
- 矿物碳氢化合物
- 丙烯酸聚合物
- 其他石化助剂
- 蛋白质
- 其他有机化学品
无机化学品
- 磷酸钙
- 金属氧化物
- 岩盐
- 碳酸钙
- 硫酸钙
- 其他无机化学品
其他化学品

药用辅料市场：按配方

市场概况
口服製剂
- 锭剂
- 胶囊
- 硬明胶胶囊
- 软明胶胶囊
- 液体配方
- 其他口服製剂
局部製剂
肠外製剂
其他配方

药用辅料市场：依功能分类

市场概况
填充剂和稀释剂
悬浮剂和黏稠剂
被覆剂
活页夹
调味剂/甜味剂
崩坏
着色剂
润滑剂和润滑剂
防腐剂
乳化剂
其他特点

药用辅料市场：依功能用途

市场概况
稳定剂
遮罩味
修復版本
提高溶解度和生物有效性
其他功能用途

药用辅料市场规模：依地区划分

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

BASF SE（Germany）
Ashland Inc.（US）
Evonik Industries AG（Germany）
Kerry Group PLC（Ireland）
Roquette Freres（France）
Merck KGaA（Germany）
Associated British Foods PLC（UK）
ADM（US）
Wacker Chemie AG（Germany）
Air Liquide（France）
Dow（US）
Lubrizol Corporation（Berkshire Hathaway）（US）
Colorcon（US）
DFE Pharma（Germany）
Innophos（US）
J. Rettenmaier & Sohne GmbH+Co KG（Germany）
Actylis（US）
Meggle GmbH & Co. KG（Germany）
Fuji Chemical Industries Co., Ltd.（Japan）
Corel Pharma Chem（India）

简介目录

Product Code: SQMIG35I2120

Global Pharmaceutical Excipients Market size was valued at USD 9.48 billion in 2022 and is poised to grow from USD 10.12 billion in 2023 to USD 17.13 billion by 2031, growing at a CAGR of 6.8% in the forecast period (2024-2031).

The global pharmaceutical excipients market is a vital component of the pharmaceutical industry, encompassing substances used alongside active pharmaceutical ingredients (APIs) to aid in drug formulation, stability, and delivery. Excipients, including binders, lubricants, disintegrants, and fillers, play a crucial role in ensuring the effectiveness and safety of medications. The market is expanding due to the increasing demand for sophisticated drug formulations, driven by an aging population, rising incidence of chronic diseases, and advancements in drug delivery systems. Additionally, excipients are being increasingly used in developing novel drug formulations, such as controlled-release and targeted therapies. Our study also reveals that growing regulatory scrutiny regarding the quality of excipients is influencing market dynamics, pushing manufacturers to focus on compliance and innovation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pharmaceutical Excipients Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pharmaceutical Excipients Market Segmental Analysis

Global Pharmaceutical Excipients Market is segmented on the basis of product, formulation, functionality, functionality application, and region. By product, market is segmented into organic chemicals, inorganic chemicals, other chemicals. By functionality, market is segmented into fillers & diluents, suspending & viscosity agents, coating agents, binders, flavoring agents & sweeteners, disintegrants, colorants, lubricants & glidants, preservatives, emulsifying agents, other functionalities. By functionality application, market is segmented into stabilizers, taste masking, modified release, solubility & bioavailability enhancement, other functionality applications. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Pharmaceutical Excipients Market

The pharmaceutical excipients market is strongly driven by the rising demand for generic drugs, especially in developing economies. As patents for blockbuster drugs expire, the production of generics is expanding, providing affordable treatment options globally. Generic drugs, which replicate the active ingredients of branded medications, rely heavily on excipients for their formulation to ensure stability, effectiveness, and safety. In markets such as India and China, where generics dominate, the demand for high-quality excipients is growing. Governments in these regions are also promoting the use of generics to reduce healthcare costs, further driving excipient demand. This trend ensures that excipients play a critical role in making medications accessible and affordable, while maintaining pharmaceutical quality standards.

Restraints in the Pharmaceutical Excipients Market

One of the key restraints affecting the pharmaceutical excipients market is stringent regulatory requirements. Excipients, although considered inactive, are subject to rigorous regulations to ensure that they do not negatively affect the quality, safety, or efficacy of the drug. Regulatory bodies such as the U.S. FDA and the European Medicines Agency impose strict guidelines for excipient use, requiring extensive testing to confirm their stability, compatibility, and safety in drug formulations. These regulations increase compliance costs for excipient manufacturers, creating a barrier to market entry for new and innovative excipients. Moreover, the regulatory process can be lengthy, often delaying the introduction of new excipients. Additionally, differences in regulatory standards across regions complicate the market, making global compliance a challenge. This stringent oversight, while ensuring drug safety, limits the speed of innovation and market expansion for excipient manufacturers.

Market Trends of the Pharmaceutical Excipients Market

A major trend in the pharmaceutical excipients market is the rising focus on biopharmaceuticals. Biopharmaceuticals, including biologics like monoclonal antibodies, proteins, and vaccines, require specialized excipients to ensure their stability, delivery, and efficacy. Unlike traditional small-molecule drugs, biopharmaceuticals present unique formulation challenges due to their sensitivity to temperature, pH, and biological interactions. This growing biopharmaceutical sector is driving innovation in excipient development, with companies focusing on creating excipients tailored to the specific needs of biologics. For instance, excipients that offer enhanced protection against degradation during storage and transportation are in high demand. As biopharmaceuticals continue to grow in prominence, particularly in developed markets like North America and Europe, the demand for these specialized excipients is expected to increase significantly.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Ecosystem of the Market
Top Investment Analysis
Key Success Factor
Degree of Competition
Pricing Analysis
Value Chain Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Landscape

Pharmaceutical Excipients Market by Product

Market Overview
Organic Chemicals
- Oleochemicals
- Fatty Alcohols
- Mineral Stearates
- Glycerin
- Other Oleochemicals
- Carbohydrates
- Sugars
- Actual Sugars
- Sugar Alcohols
- Artificial Sweeteners
- Cellulose
- Microcrystalline Cellulose
- Cellulose Ethers
- Cmc & Croscarmellose Sodium
- Cellulose Esters
- Starch
- Modified Starch
- Dried Starch
- Converted Starch
- Petrochemicals
- Glycols
- Povidones
- Mineral Hydrocarbons
- Acrylic Polymers
- Other Petrochemical Excipients
- Proteins
- Other Organic Chemicals
Inorganic Chemicals
- Calcium Phosphate
- Metal Oxides
- Halites
- Calcium Carbonate
- Calcium Sulfate
- Other Inorganic Chemicals
Other Chemicals

Pharmaceutical Excipients Market by Formulation

Market Overview
Oral Formulations
- Tablets
- Capsules
- Hard-Gelatin Capsules
- Soft-Gelatin Capsules
- Liquid Formulations
- Other Oral Formulations
Topical Formulations
Parenteral Formulations
Other Formulations

Pharmaceutical Excipients Market by Functionality

Market Overview
Fillers & Diluents
Suspending & Viscosity Agents
Coating Agents
Binders
Flavoring Agents & Sweeteners
Disintegrants
Colorants
Lubricants & Glidants
Preservatives
Emulsifying Agents
Other Functionalities

Pharmaceutical Excipients Market by Functionality Application

Market Overview
Stabilizers
Taste Masking
Modified Release
Solubility & Bioavailability Enhancement
Other Functionality Applications

Pharmaceutical Excipients Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ashland Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evonik Industries AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kerry Group PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roquette Freres (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Associated British Foods PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ADM (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wacker Chemie AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Air Liquide (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dow (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lubrizol Corporation (Berkshire Hathaway) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Colorcon (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DFE Pharma (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Innophos (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
J. Rettenmaier & Sohne GmbH + Co KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Actylis (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meggle GmbH & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fuji Chemical Industries Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corel Pharma Chem (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments